 |
New Developments in Chromatography for Improved Analytics of Biopharmaceuticals |
 |
Event Date: May 14, 2013 at 11:00 AM EDT / 8:00 AM PDT
|
Therapeutic proteins and monoclonal antibodies have transformed the biopharmaceutical industry and form the largest part of the rapidly growing biotherapeutics and biosimilars drug market. Essential to their development is the ability to quickly and accurately assess product quality and safety—including factors such as sequence integrity, titer, aggregation, charge, and glycan heterogeneity and purity—at each step. Biosimilars, which require extensive comparison to their reference products, have placed further demands on state-of-the-art analytical techniques to assess comparability and similarity.
New workflow-based analytical tools for protein analysis enable these assessments early in the development process. They provide insights that allow better, faster decisions on how to proceed with your development. This webinar will discuss new advances in state-of-the-art chromatography and mass spectrometry solutions used to support characterization, comparability, similarity, and stability studies required during biotherapeutic and biosimilar drug development and QA/QC. Learn about the new Bio-UHPLC platform and consumables for charge variant and glycan analysis.
|
Moderator:
Paul Reid
Multimedia Editor
BioPharm
Speakers:
Wim Decrop
Senior Research Scientist Chromatography
Large Molecules Chromatography Solutions Product Marketing
Thermo Fisher Scientific; Amsterdam, The Netherlands
Univ.-Prof. Mag. Dr. Christian Huber
Head of Research Group Huber
Department of Molecular Biology
Division of Chemistry and Bioanalytics
University of Salzburg, Austria
|
IMPORTANT - PLEASE READ
This is a FREE streaming audio Webcast and does not require a phone line. If you have any questions regarding this Webcast, please contact Kristen Farrell, kfarrell@advanstar.com.
Register for this FREE Webcast!
|
 |
|